Clinical trial
Topical Losartan as Treatment to Reduce Corneal Scarring Fibrosis
NCT07449000 is registered in ClinicalTrials.gov with Universidad Autonoma de Nuevo Leon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Losartan as Treatment to Reduce Corneal Scarring Fibrosis
- Lead sponsor
- Universidad Autonoma de Nuevo Leon
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 12, 2026
- Completion date
- March 1, 2027
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corneal scarring fibrosis